The Spanish Divasa-Farmavic (DFV) Group has made a significant investment in expanding its capacity to produce veterinary pharmaceuticals in Europe. These will be made both under its own brands and through contract manufacturing arrangements.
The expansion is part of the company’s 2008-12 strategic ...
Elanco Animal Health is to acquire a feed enzyme business in a move that is in line with its strategy to become involved in wider aspects of the food animal production chain.
The business, a division of Eli Lilly and Company , has agreed to acquire the ChemGen Corporation, a privately owned held ...